{"name":"Prolong Pharmaceuticals","slug":"prolong-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"EPEG","genericName":"EPEG","slug":"epeg","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"EPEG","genericName":"EPEG","slug":"epeg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPaG5kbVJRaXNYNU8wUGZGbEZQU2p2SmlGZXBPN2FWLXZxMTZhYkNSeTR2eGgwRDNhZ01GcEdaRE5rdmNDZk5GX3FNbHctaHo3YWp6VHlVaDVZX3RvMHVfbkR0by1HY1ltZnpPMHUwODJmRld1dzA0YzBKSldIMlRLS1V5elJUc3JiTWc?oc=5","date":"2026-03-20","type":"pipeline","source":"statnews.com","summary":"Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged - statnews.com","headline":"Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNZGJ4R0ZHWUJHcks0elpMMWM0MGkzenJFS25LRHhULWFJUjhyUjVheWppdjVHb1JyMTZNbHJmZUFYb1dsd29nVUFjYnhzT3ZuS1hob0lZZnB5UjRQdDRxNkhGNnQ4Yk04NnhTaWkxLThlTUpzWDFkUlp4Q2JJcXZGdm83dGdiTnczemp5alFEV1lzUdIBlwFBVV95cUxOZF84bjQ0TV9SWTQ0RDJ1XzhzMjEzTG5sVG82ZVRwTHhxLWRyem96Q3F2b3hqTG5IQllvLW5Zc3ZveWs0aFNsWFJQdW9xVHpNRWxFUWNDeVhWV21yS280cGp6dHVmU0JNTUFSQlpvV252ZWc1WmRXREpBTW1IN2RjbVpVVzBNNVlmNjlidFF1VEdZemMzR0pZ?oc=5","date":"2026-03-16","type":"patent","source":"CNBC","summary":"Strait of Hormuz standoff puts supply of America's generic drug prescriptions at risk - CNBC","headline":"Strait of Hormuz standoff puts supply of America's generic drug prescriptions at risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNSTJ4ZV8ySHdtLU5BVHZwY0VkUXZ6cjJqY3BJWHdQNzIwWENmUjhaNVo3c0txVk10WmFoTmdlN2ZkNFd2YjI3Y2NkcVhUcExrOHk2RXZ1a0RZeFcwekRDajlGcXAtUkp5amdTNHdIXzVMcWdCQ2ZFVEFCUjJtd1NmSlh6Ykd6NUVfU3Vhdm1NUQ?oc=5","date":"2026-02-26","type":"deal","source":"statnews.com","summary":"Cigna, extending reach into prescription drugs, acquires major pharmacy used by hospitals - statnews.com","headline":"Cigna, extending reach into prescription drugs, acquires major pharmacy used by hospitals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxOYTRqVnIwY0QxQzN6SWkzYmFQLXZQLXNhaFptYngxYmh4QWt2UzJsS0Y0OEs4XzdRWGtpZFBfTGlvSzcxVnl0SkR4ckRLTHRyOVplVHYtMm5XeG9TUnJZOGIwazBPOGU3ZzM3YVhWWjZ0SWNLX0hfU2tiYWxDY0FrM0RBSXptMmdrRHpHbl9kb2ludng3WWVpMEhmZGpvdVkxbkRoMFhYaXhMeFFyQnlma25NalAyY1RrSG9YSWhLX2ZtZnNpNXdCYmtfTGJMSTUzY3hSTkZZSWxYVXNSOXljaHhaNHk3cXRlM09JMXl2dFJOSHRxWmhmaWlsc250X1RKalN0YURRLTg2UVd3ZEFwTGluOC1OOTJXeVBZNlNCckpKeUtUUVhjUkppeFVFRWZVR1NN?oc=5","date":"2026-01-20","type":"pipeline","source":"patient.info","summary":"Class 2 Medicines Recall: Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes, EL(26)A/01 - patient.info","headline":"Class 2 Medicines Recall: Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for inje","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-15","type":"pipeline","source":"medicaldialogues.in","summary":"Parliamentary Panel Raps DoP, NPPA for 5-Year Delay in Trade Margin Rationalisation Under DPCO - medicaldialogues.in","headline":"Parliamentary Panel Raps DoP, NPPA for 5-Year Delay in Trade Margin Rationalisation Under DPCO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPWkJpU01Zd0lreXVMczhlS09kT0JObExSenRBSExidkR1REI5dFgxNU9lMW8yYTZiSGRJZmlpazQ1QUc0V3JZYXJrakRwdERDaE1zekRYXzV2enNtYV9nVTBhcGR3RnF2Z1cyV3R5bVJKUXh3V1ZNN2hkX1JqeEpveTV2RkZWSy1EeGhQOURzV3F4QnJVSy1za25XUnlEN0JybGJzWlJrOVJsa2xvbHNtVXhGUVdRSHZqaXhOaUdPRGRXR2YwbWpNSjFfWVN6U1hQTFAzVzNLMA?oc=5","date":"2025-12-12","type":"pipeline","source":"reuters.com","summary":"EU committee backs extending use of Lilly's diabetes drug for children aged 10 and above - reuters.com","headline":"EU committee backs extending use of Lilly's diabetes drug for children aged 10 and above","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTV4LUs3WFY4UWdGZnVHQ09jd3lZQWxpY1JWcVV5OE9oOURFUGMyNUxKbm9yb25HNHFkVTRCUzhXUGVEOUNSU0JQQ2M2UnlFOXVBeld3T2l1Y0F1eEJrLTJ0eTJNYWJ1OFJMMTR3aTd4S2w2WlFIZEdweTBGc3ZYc3dOVmRiU0ljb0o3d2ptcW5uYTdxdklNMHFaRzlNYUI4LTd2N2NUdXBVaUloTkZIaW1qUEs3X0xORlFlbzhXUmdMTV90eU5OSXhZeExXN0VKVGlHMzF0bkJ6QklsNDFfQjBIMmFhbmRjb3NfWEFZYzM5ZW1GN3VRN0xVY0dnRV9EcEVSMzA5bzNOcW9BYV9GN2c1ME1ZNGE1U1RkRmFUOXpyRkkzQmc?oc=5","date":"2025-10-20","type":"trial","source":"Business Wire","summary":"Prolong Pharmaceuticals to Present Phase 1/2 Data from HEMERA-1 for PP-007 in Acute Ischemic Stroke (AIS) at the 2025 World Stroke Conference (WSC) - Business Wire","headline":"Prolong Pharmaceuticals to Present Phase 1/2 Data from HEMERA-1 for PP-007 in Acute Ischemic Stroke (AIS) at the 2025 Wo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNVmRza0tHdjFXRURZczduMUNDRXNKNHdZOW91djZVR3d4WkVPbXpkdlh3RkduZHlOQzlQb3BpZWFxcXRVb3ptRlhoNEZXcTlwT2kwTzl4TFFlbms0cXRvell6UjIxNl9iV1ZlcldQZFdVdFRuMG5WVUtTVkJXNnVJNlZtbmlLSXZlb1JCekh5Z1FfaUZrSkRMcHJ3QUl5UURu?oc=5","date":"2025-10-14","type":"regulatory","source":"Fierce Biotech","summary":"Denali's Hunter syndrome drug latest to be hit by FDA decision delay - Fierce Biotech","headline":"Denali's Hunter syndrome drug latest to be hit by FDA decision delay","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5OOHpHeUFrZzh2LUthdXQ1SEFxRExQYWxTSENoQldtRWlwV2dqdzZlQ201Z0hSNTFzZ2JJYWZ1OGdtcDI1VnlEc0hSNW50UUMtOUZV?oc=5","date":"2025-10-13","type":"regulatory","source":"FirstWord Pharma","summary":"Problems at Novo site may prolong regulatory delays for Scholar Rock, Regeneron - FirstWord Pharma","headline":"Problems at Novo site may prolong regulatory delays for Scholar Rock, Regeneron","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPUkNMWThnUGxOY1JZeTZ6dGZHbWMtUHMwWC1pYTgwdThOYzQ5ZFRvM2FyWmlfeHF6aG5XaGtiSWtINkpST0loZTVXOWNMTXhmeGtWRUlFSUNoMDdlUWE3dEhpMGZUcDVCMDVodUVvVGZScmwwcWlSODZZQ3lFVXdsQlBNcWpTWVlKYm5Bd3VkOE9UYXM4WlZtX1RlMkhRRmZzQ1d3NS1mdjZvcGhE?oc=5","date":"2025-09-23","type":"regulatory","source":"Fierce Pharma","summary":"FDA rejects Scholar Rock's SMA drug, citing issues at Novo's Catalent Indiana site - Fierce Pharma","headline":"FDA rejects Scholar Rock's SMA drug, citing issues at Novo's Catalent Indiana site","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOVm5ELVZOay1vNG9URHY4d0NnZXJuUm5wM3FBcVhqblNmZU83ZFduaUMyeUxHMlVNQ2VBS2Q1QXhKRl9qaEtualViSFJYYzdWdzVLMldFNUhPd3dFRjNUTFFaVzhSVFJpR3hiZXFxWDdta0xDWkpvQm9RNjRmRmlwdHhJWVZqMXlBZlBGRDA5M3J0bmNxZ1ZFTFVrYi1OVXUwM0xFVGFReWM4clVkWm1wR1M2cEgwYXVwSlQxYk1ZOA?oc=5","date":"2025-08-27","type":"pipeline","source":"Pharmaceutical Commerce","summary":"DSCSA Distributor Exemption Ends, Marking Major Milestone in Pharma Supply Chain Security - Pharmaceutical Commerce","headline":"DSCSA Distributor Exemption Ends, Marking Major Milestone in Pharma Supply Chain Security","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxObVRTNGdCZWtxYk40MXpHaGJYVDVFTDByVVlYdXBtSThsUEpRaTA5bG9mQ185ZERaLWFMdE5NS2diYm42TnBFWVFwZkk5cS00cVZQN19vLXpZLTIzTkhNR3UzTHFIX0dUY1JmNHZ6bXJKQUVwcE1pT2RDQU05TXFMcGQxc0wwZENkNzhNZTIwYw?oc=5","date":"2025-08-04","type":"pipeline","source":"Pharma Voice","summary":"Drugmakers score policy win in a prolonged fight against 340B - Pharma Voice","headline":"Drugmakers score policy win in a prolonged fight against 340B","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}